Bernard Abramovici

Title: Bernard Abramovici: Innovator in Pharmaceutical Compositions

Introduction

Bernard Abramovici is a notable inventor based in Juvignac, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the efficacy of antiarrhythmic medications. With a total of seven patents to his name, Abramovici's work has had a considerable impact on the medical community.

Latest Patents

Among his latest patents is a pharmaceutical composition and dosage form comprising dronedarone. This invention focuses on a composition for oral administration that includes a benzofuran derivative with antiarrhythmic activity. The composition is designed to limit the meal time effect following oral administration in humans. The inclusion of a lipid carrier allows for the solubilization of the active principle and protects it from the negative effects of pH in the intestinal tract. Another significant patent involves solid pharmaceutical compositions containing benzofuran derivatives, which are characterized by their inclusion of a nonionic hydrophilic surfactant and other pharmaceutical excipients.

Career Highlights

Throughout his career, Bernard Abramovici has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Synthelabo. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Abramovici has collaborated with notable professionals in his field, including Jean-Claude Gromenil and Jean-Claude Gautier. These collaborations have likely enriched his research and development efforts, leading to the successful patents he holds today.

Conclusion

Bernard Abramovici's contributions to pharmaceutical innovations, particularly in antiarrhythmic compositions, highlight his role as a significant inventor in the industry. His work continues to influence the development of effective medical treatments.